Search

Your search keyword '"Camm, A. John"' showing total 3,025 results

Search Constraints

Start Over You searched for: Author "Camm, A. John" Remove constraint Author: "Camm, A. John"
3,025 results on '"Camm, A. John"'

Search Results

1. Undertaking multi-centre randomised controlled trials in primary care: learnings and recommendations from the PULsE-AI trial researchers

2. Combined atrial fibrillation ablation and left atrial appendage occlusion procedure in the United States: a propensity score matched analysis from 2016–2019 national readmission database

3. Orally Inhaled Flecainide for Conversion of Atrial Fibrillation to Sinus Rhythm: INSTANT Phase 2 Trial

9. Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation

10. Multicenter, Phase 2, Randomized Controlled Study of the Efficacy and Safety of Etripamil Nasal Spray for the Acute Reduction of Rapid Ventricular Rate in Patients With Symptomatic Atrial Fibrillation (ReVeRA-201)

11. A randomized controlled trial to investigate the use of acute coronary syndrome therapy in patients hospitalized with COVID-19: the COVID-19 Acute Coronary Syndrome trial

12. Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial

21. Anticoagulation in Patients With Device-Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH-AFNET 6 Trial.

22. Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

24. Blood-based cardiometabolic phenotypes in atrial fibrillation and their associated risk: EAST-AFNET 4 biomolecule study

25. Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial

28. Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference

29. First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301)

33. Consumer wearable devices for evaluation of heart rate control using digoxin versus beta-blockers: the RATE-AF randomized trial

34. Risks and benefits of sharing patient information on social media:a digital dilemma

35. Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 h

36. Longer and better lives for patients with atrial fibrillation : the 9th AFNET/EHRA consensus conference

37. Longer and better lives for patients with atrial fibrillation:the 9th AFNET/EHRA consensus conference

38. Treatment strategies of the thromboembolic risk in kidney failure patients with atrial fibrillation.

39. Causes of death in patients with atrial fibrillation anticoagulated with rivaroxaban: a pooled analysis of XANTUS.

40. Safety and efficacy of long-term sodium channel blocker therapy for early rhythm control: the EAST-AFNET 4 trial.

41. Practical Guide on Left Atrial Appendage Closure for the Non-implanting Physician. An International Consensus Paper

47. Consumer wearable devices for evaluation of heart rate control using digoxin versus beta-blockers: the RATE-AF randomized trial

48. Direct Oral Anticoagulants for Stroke Prevention in Patients with Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials

49. Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation

50. Anticoagulation with edoxaban in patients with long Atrial High-Rate Episodes ≥24 hours

Catalog

Books, media, physical & digital resources